Nothing Special   »   [go: up one dir, main page]

JPS61183263A - Manufacture of pyrrolidine derivative - Google Patents

Manufacture of pyrrolidine derivative

Info

Publication number
JPS61183263A
JPS61183263A JP60282703A JP28270385A JPS61183263A JP S61183263 A JPS61183263 A JP S61183263A JP 60282703 A JP60282703 A JP 60282703A JP 28270385 A JP28270385 A JP 28270385A JP S61183263 A JPS61183263 A JP S61183263A
Authority
JP
Japan
Prior art keywords
compound
formula
producing
reaction
carried out
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60282703A
Other languages
Japanese (ja)
Inventor
キ キム ドン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boryung Pharmaceutical Co Ltd
Original Assignee
Boryung Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boryung Pharmaceutical Co Ltd filed Critical Boryung Pharmaceutical Co Ltd
Publication of JPS61183263A publication Critical patent/JPS61183263A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明ば式(I)化合物の新しい製造方法に関する。こ
の化合物は血圧を降下させ高血圧症を防くために有効で
ある。
DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a new method for producing compounds of formula (I). This compound is effective in lowering blood pressure and preventing hypertension.

(従来の技術) 多くの発明家にまり式(I)化合物の様々な合成方法が
研究されている。例えば、 U、S、 I”at、 N
a4297282号公報には、アルコール性アンモニア
水を用いたN−(D−α−メチル−β−アセチルチオプ
ロピオニル)−L−プロリンの脱アシル化による所望物
質の調製方法が開示されている。
(Prior Art) Various methods for synthesizing compounds of formula (I) have been studied by many inventors. For example, U, S, I"at, N
A4297282 discloses a method for preparing a desired substance by deacylation of N-(D-α-methyl-β-acetylthiopropionyl)-L-proline using alcoholic aqueous ammonia.

特開昭56−100760号公報には、1−(3−ブロ
モ−(2S)−メチルプロピオニル)ピロリジン−(2
S) −−カルボン酸とチオ硫酸すl・リウムとを反応
させてブンテ塩(Bunte 5alt)を得た後、こ
のブンテ塩を塩酸を用いて加水分解することにより。
JP-A-56-100760 discloses 1-(3-bromo-(2S)-methylpropionyl)pyrrolidine-(2
S) --By reacting carboxylic acid with sulfur thiosulfate to obtain Bunte salt (Bunte 5alt), and then hydrolyzing this Bunte salt with hydrochloric acid.

所望物質を生成する方法が開示されている。A method of producing a desired substance is disclosed.

ピロリジン誘導体は公知であり、 U、S、 Pat、
 Na4046889号公報に記載の手順により得られ
る。すなわち、1−(3−アルキル力ルホニル チオ−
2−メチルプロピオニル)−■、−プロリンのアルキル
エステルは、アニソールとトリフルオロ酢酸で処理され
2その遊離酸が得られる。このように得られた遊離酸は
、アルコール性アンモニア水または濃縮されたアンモニ
ア水溶液と反応することにより、アンモニア化(アンモ
ノリシス)されるかあるいは、アルカリ金属の水酸化物
水冷液と反応するごとにより加水分解され、その結果、
所望の1−(3−メルカプト−2−メチルプロピオニル
)−I7−プロリンが得られる。
Pyrrolidine derivatives are known and include U, S, Pat,
Obtained by the procedure described in Na4046889. That is, 1-(3-alkyl sulfonyl thio-
The alkyl ester of 2-methylpropionyl)-■,-proline is treated with anisole and trifluoroacetic acid to yield the free acid. The free acid thus obtained is either ammoniated (ammonolysis) by reaction with alcoholic aqueous ammonia or concentrated aqueous ammonia solution, or hydrated by reaction with an aqueous alkali metal hydroxide solution. decomposed, and as a result,
The desired 1-(3-mercapto-2-methylpropionyl)-I7-proline is obtained.

前記のような公知の方法では、硫化物が容易に還元され
ず、そのために生成物の収率があまり高くならないとい
う欠点を有する。本発明はこれらの欠点を除き、弐(I
)化合物の新規かつ有利な製造方法を提(ILする。
Known processes such as those described above have the disadvantage that the sulfides are not easily reduced and therefore the product yields are not very high. The present invention eliminates these drawbacks and
) We present a new and advantageous method for the preparation of compounds (IL).

このように1本発明は式(I)化合物の製造方法を提供
するものてあり、ごの方法は1式(I■)化合物と式(
TV)化合物とを反応させて式(I)化合物を得る工程
および式(II)化合物と塩基とを反応させて式(I)
化合物を得る工程を包含する。
As described above, the present invention provides a method for producing a compound of formula (I), and the method includes a method for producing a compound of formula (I) and a compound of formula (I).
TV) A step of reacting a compound with a compound of formula (I) to obtain a compound of formula (I) and a step of reacting a compound of formula (II) with a base to obtain a compound of formula (I)
The method includes a step of obtaining a compound.

■ C]13 門’S−−−C−Y −(R) ll      ・・
・・・・(IV)ここて。
■C] 13 Gate'S---C-Y-(R) ll...
...(IV) Here.

Xは臭素または塩素。X is bromine or chlorine.

Y i;+酸素原子または窒素原子。Y i; + oxygen atom or nitrogen atom.

RばC,−C,、の低級アルキル基。R is a lower alkyl group of C, -C,.

nは1または2である整数(Yが窒素ならnば2、そし
てYが酸素ならnば1)。
n is an integer of 1 or 2 (if Y is nitrogen, n is 2; if Y is oxygen, n is 1).

門はすI・リウ広原子またはカリウム原子である。The gate is the I. Liu broad atom or the potassium atom.

さらに本発明Lj: 、式(TI)化合物を加水分解も
しくはヒドラジン分解、あるいはエチレンジアミンと反
応させるという点で、弐N)化合物を新規かつ効率よく
得る方法を提供する。
Furthermore, the present invention provides a novel and efficient method for obtaining the compound of formula (TI) by hydrolysis or hydrazinolysis, or by reacting it with ethylenediamine.

加水分解の場合、炭酸ナトリウム、水酸化ナトリウム、
炭酸カリウム、水酸化カリウム、アンモニア水のような
塩基が5式(n)化合物1モルに対し、1〜5モルの量
で使用される。反応に用いられる溶媒には、水、メタノ
ール、エタノール。
For hydrolysis, sodium carbonate, sodium hydroxide,
A base such as potassium carbonate, potassium hydroxide, or aqueous ammonia is used in an amount of 1 to 5 moles per mole of the compound of formula 5 (n). The solvents used in the reaction include water, methanol, and ethanol.

イソプロパツール、アセ1〜ン、1.4−シオキザン、
テトラヒドロフラン、N、N−ジメチルボルムアミド、
ジメチルスルホキシドまたll水と上記有機溶媒との混
合溶媒がある。反応温度は40℃と130℃との間であ
る。
Isopropanol, acetate, 1,4-thioxane,
Tetrahydrofuran, N,N-dimethylbormamide,
There is also a mixed solvent of dimethyl sulfoxide or 11 water and the above organic solvent. The reaction temperature is between 40°C and 130°C.

ヒドラジン分解の場合2式(TI)化合物は無水ヒドラ
ジンまたはヒドラジン水化物と反応溶媒中で接触させら
れ、弐(I)化合物が形成される。
In the case of hydrazinolysis, the compound of formula 2 (TI) is contacted with anhydrous hydrazine or hydrazine hydrate in a reaction solvent to form the compound 2 (I).

無水ヒドラジンまたはヒドラジン水化物は2式(■)化
合物1モルに対し、1〜5モル量で使用されうる。反応
は40〜130℃の範囲の温度で行われうる。加水分解
に用いられる溶媒と同一の溶媒が。
Anhydrous hydrazine or hydrazine hydrate may be used in an amount of 1 to 5 moles per mole of the compound of formula 2 (■). The reaction may be carried out at a temperature ranging from 40 to 130°C. The same solvent used for hydrolysis.

ヒドラジン分解でも使用可能である。It can also be used for hydrazinolysis.

また2式(TI)化合物をエチレンシアミンと反応させ
て弐N)化合物を得る場合1式(n)化金物1モルに対
し、1〜10モルの量のエチレンジアミンが、10〜8
0℃の範囲の温度で使用される。
In addition, when the compound of formula 2 (TI) is reacted with ethylenecyamine to obtain the compound 2N), 1 to 10 mol of ethylenediamine is added to 1 mol of the metal compound of formula 1 (n).
Used at temperatures in the range of 0°C.

反応に用いられる溶媒は、四塩化炭素、クロロホルム、
塩化メチレン、酢酸エチル、テ1〜ラヒドロフラン、1
.4−ジオキサンまたはアルコール類を包含し、場合に
よっては2反応は溶媒なしで行なわれる。
The solvent used for the reaction is carbon tetrachloride, chloroform,
methylene chloride, ethyl acetate, 1-rahydrofuran, 1
.. Including 4-dioxane or alcohols, in some cases the two reactions are carried out without solvent.

本発明の式(n)化合物は1式(II+)化合物1モル
と式(IV)化合物1〜3モルとを2塩基の存在下溶媒
中で反応させることにより、調製される。
The compound of formula (n) of the present invention is prepared by reacting 1 mole of a compound of formula (II+) with 1 to 3 moles of a compound of formula (IV) in a solvent in the presence of two bases.

溶媒は、水、メタノール、エタノール、イソプロパツー
ル、アセトン、1,4−ンオキザン、テトラヒドロフラ
ン、 N、 N−ジメチルポルムアミド、ジメチルスル
ホキシドのような加水分解で用いた溶媒と同一の溶媒ま
たはそれらの水溶液でよい。塩基としては、炭酸水素ナ
トリウム、炭酸すl−リウム、水酸化ナトリウム、炭酸
水素カリウム。
The solvent is the same solvent used in the hydrolysis, such as water, methanol, ethanol, isopropanol, acetone, 1,4-oxane, tetrahydrofuran, N, N-dimethylpolamide, dimethyl sulfoxide, or an aqueous solution thereof. That's fine. Bases include sodium hydrogen carbonate, sulfurium carbonate, sodium hydroxide, and potassium hydrogen carbonate.

炭酸カリウム、水酸化カリウムもしくは酢酸ナトリウム
のような無機塩基1またはピリジンもしくはトリエチル
アミンのような有機塩基が使用可能である。塩基は3式
(rll)化合物1モルに対し。
Inorganic bases such as potassium carbonate, potassium hydroxide or sodium acetate or organic bases such as pyridine or triethylamine can be used. The base is per mole of the compound of formula 3 (rll).

0.5〜2.5モルの量で用いられる。It is used in an amount of 0.5 to 2.5 moles.

反応は、35〜120℃の範囲のl晶度で30分から2
0時間行われうる。
The reaction was carried out for 30 minutes to 2 hours at a crystallinity in the range of 35-120°C.
It can be carried out for 0 hours.

本発明の方法を行って所望の生成物を得る際に。In carrying out the process of the invention to obtain the desired product.

以下の実施例に既述の手順に従って1分離、結晶化およ
び最終的な精製がなされてもよい。
Isolation, crystallization and final purification may be carried out according to the procedures described in the Examples below.

(実施例) 以下の実施例にて本発明の詳細な説明する。しかしなが
ら、それによって本発明を限定するつもりがないことは
明らかである。
(Example) The present invention will be explained in detail in the following example. However, it is clear that there is no intention to limit the invention thereby.

lIH舛」− 1−(3−ブロモ−(2S) −メチルプロピオニル)
−ピロリジン−(2S)−カルボン酸5.64gを蒸留
水40m7!に熔解させた後、ジエヂルシチオ力ルハミ
ド酸り゛トリウム4.96gを加えた。
1-(3-bromo-(2S)-methylpropionyl)
-Pyrrolidine-(2S)-carboxylic acid 5.64g in distilled water 40m7! After the mixture was dissolved, 4.96 g of diethylthiolhydramide acid salt was added.

混合物を80〜85℃に加熱し、ごの温度で4時間攪拌
した後、室温まで冷却した。pH値は濃塩酸で1.0に
調整した。その後、混合物を塩化メチレン40+nI!
で2回抽出し、有機層を硫酸マグネシウムで乾燥した後
、減圧下で蒸留した。
The mixture was heated to 80-85°C and stirred at room temperature for 4 hours, then cooled to room temperature. The pH value was adjusted to 1.0 with concentrated hydrochloric acid. The mixture was then mixed with 40+nI! of methylene chloride!
The organic layer was dried over magnesium sulfate and then distilled under reduced pressure.

水酸化カリウム9.8gを蒸留水35m7!に溶解させ
、溶液をこの残留物に加えて8時間還流した。
9.8g of potassium hydroxide and 35m7 of distilled water! The solution was added to this residue and refluxed for 8 hours.

混合物をエチルエーテル20m1で2回洗浄し。The mixture was washed twice with 20 ml of ethyl ether.

室温下、p11値を濃塩酸で1.0に調整した。その後
The p11 value was adjusted to 1.0 with concentrated hydrochloric acid at room temperature. after that.

この混合物を塩化メチレン40mffで2回抽出し。This mixture was extracted twice with 40 mff of methylene chloride.

飽和塩化すトす・:ノム熔液で洗浄した。さらに、硫酸
ナトリウムで乾燥し、濾過して減圧下で蒸留し1ま た。
Washed with saturated chloride solution. Further, it was dried over sodium sulfate, filtered, and distilled under reduced pressure.

この残留物に対し2.  I N l12SO450m
I2および亜鉛パウダー0.1gを加えて室温下で2時
間IW拌した。混合物をエチルエーテル10m j!で
2回、そして酢酸エチル45m Nで2回洗浄した後、
抽出された有機層を乾燥、濾過し、減圧下で蒸留し7て
油状の残留物を得た。このように得られだ油状の残留物
を酢酸エチル4m7!およびエチルエーテル5m7!に
加え、室温下で1時間攪拌した。沈澱物を濾過。
2. For this residue. I N l12SO450m
I2 and 0.1 g of zinc powder were added, followed by IW stirring at room temperature for 2 hours. Pour the mixture into ethyl ether 10mj! and twice with 45 mN ethyl acetate,
The extracted organic layer was dried, filtered, and distilled under reduced pressure to obtain an oily residue. The oily residue thus obtained was mixed with 4 m7 of ethyl acetate! and 5m7 of ethyl ether! and stirred at room temperature for 1 hour. Filter the precipitate.

洗浄し乾燥した^ごろ、]−(]3−メルカプト−2S
)−メチルプロピオニル)−ピlコリジン−(2S)−
カルボン酸3.95gが得られた。
After washing and drying, ]-(]3-mercapto-2S
)-Methylpropionyl)-pylcolidine-(2S)-
3.95 g of carboxylic acid was obtained.

門、P、:103℃〜104℃〔 α) P−129,5° (c −1,0ELOII)
大協−1ンU− 1−(3−ブ「lモー (23)−メチルプロピオニル
)−ピロリジン−(2S) −カルボン酸2.82gを
エタノール40m eに?容解さゼ°、この?容液に、
ジメチルジヂオカルハミン酸ナトリウム2.4gを加え
た。混合物を6時間iW流し、室温まで冷却して濾過し
た。
Gate, P: 103℃~104℃〔α) P-129,5° (c -1,0ELOII)
Dissolve 2.82 g of Daikyo-1-U-1-(3-B)-(23)-methylpropionyl)-pyrrolidine-(2S)-carboxylic acid in 40mE of ethanol, and then dissolve this liquid. To,
2.4 g of sodium dimethyl didiocarhamate was added. The mixture was passed iW for 6 hours, cooled to room temperature and filtered.

この濾液にヒドラジン水化物10mj!を加え、ジメチ
ルアミンがすべて追い出されるまで還流した後、減圧下
で蒸留した。
Add 10mj of hydrazine hydrate to this filtrate! was added and refluxed until all dimethylamine was expelled, followed by distillation under reduced pressure.

この結果化じた残留物に蒸留水35m 1を加え。35 ml of distilled water was added to the resulting residue.

pH値を濃塩酸で1.0に調整した。The pH value was adjusted to 1.0 with concentrated hydrochloric acid.

その後、混合物をエチルエーテル]Om (4で3回洗
浄し、酢酸エチル40m1lで2回抽出した。抽出され
た有機層を乾燥、濾過し、減圧下で蒸留して油状の残留
物2.1gを得た。
The mixture was then washed three times with ethyl ether]Om (4) and extracted twice with 40 ml of ethyl acetate. The extracted organic layer was dried, filtered and distilled under reduced pressure to obtain 2.1 g of an oily residue. Obtained.

このように得られた油状の残留物を酢酸エチル2mlお
よびバーへキザン3 mllに加え、2時間攪拌した。
The oily residue thus obtained was added to 2 ml of ethyl acetate and 3 ml of Barhexanes and stirred for 2 hours.

沈澱物を濾過してn−ヘキサンで洗浄し2次いで一昼夜
乾燥させて1−(3−メルカプ1−−(2S)−メチル
プロピオニル)ピロリジン−(2S)−カルボン酸1.
8gを得た。
The precipitate was filtered, washed with n-hexane, and then dried overnight to obtain 1-(3-mercap 1-(2S)-methylpropionyl)pyrrolidine-(2S)-carboxylic acid.
8g was obtained.

門、′P、=103℃〜104℃ 〔α〕65−−129.8° (’c”−= 1,0 
; EtOll)丈逓雌は 1−(3−クロロ−(2S)−メチルプロピオニル)−
ピロリジン−(2S)−カルボン酸2.23’gをアセ
トン30m 1!に?容解させ、ごの?容ン夜にキサン
トゲン酸カリウム1.76gを加えた。混合物を10時
間還流した後、濾過して沈澱物を除去した。濾液を減圧
下で蒸留した後、そこに酢酸エチル50m 7!および
飽和塩化ナトリウム溶液15m 7!を加え、相分離し
た。有機層を硫酸マグネシウムで乾燥し、減圧下で蒸留
した。
Gate, 'P, = 103℃ ~ 104℃ [α] 65--129.8° ('c''-= 1,0
; EtOll) length is 1-(3-chloro-(2S)-methylpropionyl)-
2.23'g of pyrrolidine-(2S)-carboxylic acid and 30ml of acetone 1! To? Let me understand, please? At the same time, 1.76 g of potassium xanthate was added. The mixture was refluxed for 10 hours and then filtered to remove the precipitate. After distilling the filtrate under reduced pressure, 50 m of ethyl acetate was added thereto. and 15 m of saturated sodium chloride solution 7! was added and the phases were separated. The organic layer was dried over magnesium sulfate and distilled under reduced pressure.

このように得られた残留物をエチレンジアミン3.5+
nj2に加え、混合物を、乾燥窒素ガスの気流下。
The residue thus obtained was mixed with ethylenediamine 3.5+
nj2 and the mixture under a stream of dry nitrogen gas.

30℃で3.5時間攪拌した。この混合物を室温まで冷
却し、p11値を10%11□S04で1.0に調整し
た。その後、亜鉛パウダー0.05gを加えて室温下で
2時間攪拌した。混合物をエチルエーテルで洗浄し。
The mixture was stirred at 30°C for 3.5 hours. The mixture was cooled to room temperature and the p11 value was adjusted to 1.0 with 10% 11□S04. Thereafter, 0.05 g of zinc powder was added and stirred at room temperature for 2 hours. Wash the mixture with ethyl ether.

酢酸エチル35m1で2回抽出した。さらに飽和塩化ナ
トリウム溶液で洗浄し、硫酸すl・リウムで乾燥、濾過
して減圧下で蒸留したところl(:3−メルカプ1−−
(2S)−メチルプロピオニル)−ピロリジン−(2S
)−カルボン酸1.0gが得られた。
Extracted twice with 35 ml of ethyl acetate. It was further washed with saturated sodium chloride solution, dried over sulfur sulfate, filtered and distilled under reduced pressure.
(2S)-Methylpropionyl)-pyrrolidine-(2S
)-carboxylic acid 1.0 g was obtained.

門、P、:103℃〜 105℃(( X〕P=−128,86(c =1.0  ; P、t
oIl)尖旌張り丈 1−(3−ブロモ−(2S)−メチルプロピオニル)−
ピロリジン−(2S)−カルボン酸2.23gおよび水
酸化ナトリウム0.4gを50%アセI・ン水溶?夜3
0m1に?容解さセ、この?容液にキサン1−ゲン酸カ
リウム1.8gを加えた。混合物を8時間還流した後、
減圧下で蒸留してアセトンを除去した。混合物を室温下
に保ち、濃塩酸でr、lI値を1.0に調整した。
Gate, P: 103°C to 105°C ((X) P = -128,86 (c = 1.0; P, t
oIl) Tip length 1-(3-bromo-(2S)-methylpropionyl)-
2.23 g of pyrrolidine-(2S)-carboxylic acid and 0.4 g of sodium hydroxide were dissolved in 50% acetic acid solution in water. night 3
To 0m1? Is this acceptable? 1.8 g of potassium xane-1-genate was added to the solution. After refluxing the mixture for 8 hours,
Acetone was removed by distillation under reduced pressure. The mixture was kept at room temperature and the r, lI values were adjusted to 1.0 with concentrated hydrochloric acid.

pn調整のされた混合物を、塩化メチレン35m (4
で抽出した。抽出された有機層を硫酸マグネシウムで乾
燥した後、減圧下で蒸留して残留物を得た。
The pn-adjusted mixture was mixed with 35 m (4 m) of methylene chloride.
Extracted with. The extracted organic layer was dried over magnesium sulfate and then distilled under reduced pressure to obtain a residue.

このように得られた残留物にエチレンジアミン3.6m
ffを加え、混合物を、乾燥窒素ガスの気流下。
To the residue thus obtained was added 3.6 m of ethylenediamine.
ff and the mixture under a stream of dry nitrogen gas.

35℃で3時間攪拌した。この混合物を室温まで冷却し
、p11値を15%硫酸で1.0に調整して1時間攪拌
した。その後、混合物をエチルエーテルで洗浄し、塩化
メチレン40m j!で2回抽出した。さらにそのあと
で2分離された有機層を乾燥し、濾過して減圧下で蒸留
した。
The mixture was stirred at 35°C for 3 hours. The mixture was cooled to room temperature, the p11 value was adjusted to 1.0 with 15% sulfuric acid, and stirred for 1 hour. The mixture was then washed with ethyl ether and methylene chloride 40mj! Extracted twice. Thereafter, the two separated organic layers were dried, filtered, and distilled under reduced pressure.

このように得られた油状の残留物をエーテル3m7!お
よび酢酸エチル2mρに加え、室温ドで2時間攪拌し、
濾過した。次いで240℃で一昼夜乾燥したところ1−
(3−メルカプl= −(2S)  −メチルブlコピ
オニル)−ピロリジン−(2S)−カルボン酸が得られ
た。
The oily residue thus obtained was mixed with 3 m7 of ether. and 2 mρ of ethyl acetate, stirred at room temperature for 2 hours,
Filtered. Then, after drying at 240°C for a day and night, 1-
(3-Mercapl=-(2S)-methylbrocopionyl)-pyrrolidine-(2S)-carboxylic acid was obtained.

M、P、 :  IO2,5’C〜105℃〔α) F
=”=  130.0° (c =1,0 、 EtO
tl)(発明の効果) 本発明によれば、このように、 (I)式で示されるピ
ロリジン誘導体が高収率で得られる。この化合物は、血
圧を陸上させ高血圧症を防ぐために有効である。
M, P,: IO2,5'C~105℃ [α) F
=”= 130.0° (c = 1,0, EtO
tl) (Effects of the Invention) According to the present invention, the pyrrolidine derivative represented by the formula (I) can be obtained in high yield. This compound is effective in lowering blood pressure and preventing hypertension.

Claims (1)

【特許請求の範囲】 1、式( I )化合物の製造方法であって、式(III)化
合物を式(IV)化合物と反応させて式(II)化合物を得
る工程、および式(II)化合物を加水分解もしくはヒド
ラジン分解、あるいはエチレンジアミンと反応させて、
式( I )化合物を得る工程、を包含するピロリジン誘
導体の製造方法:▲数式、化学式、表等があります▼・
・・( I ) ▲数式、化学式、表等があります▼・・・(II) ▲数式、化学式、表等があります▼・・・(III) ▲数式、化学式、表等があります▼・・・(IV) ここで、 Xは臭素または塩素、 Yは酸素原子または窒素原子、 RはC_1〜C_5の低級アルキル基、 nは1または2である整数(Yが窒素な らnは2、そしてYが酸素ならnは1)、 Mはナトリウム原子またはカリウム原子 である。 2、式(III)化合物と式(IV)化合物との反応が、水
、メタノール、エタノール、イソプロパノール、アセト
ン、1,4−ジオキサン、テトラヒドロフラン、N,N
−ジメチルホルムアミドおよびジメチルスルホキシドの
うちの少なくとも一種の溶媒またはそれらの水溶液中で
行われる特許請求の範囲第1項に記載のピロリジン誘導
体の製造方法。 3、式(IV)化合物が、式(III)化合物1モルに対し
、1〜3モルの量で反応に供される特許請求の範囲第2
項に記載のピロリジン誘導体の製造方法。 4、反応温度か35℃と120℃との間で、反応時間が
30分と20時間との間である特許請求の範囲第2項に
記載のピロリシン誘導体の製造方法。 5、炭酸水素ナトリウム、炭酸ナトリウム、水酸化ナト
リウム、炭酸水素カリウム、炭酸カリウム、水酸化カリ
ウム、酢酸ナトリウム、ピリジンおよびトリエチルアミ
ンのうちの少なくとも一種の塩基が、式(III)化合物
1モルに対し、0.5〜2.5モルの量で使用される特
許請求の範囲第2項に記載のピロリシン誘導体の製造方
法。 6、式(II)化合物の加水分解が、水酸化カリウム、炭
酸カリウム、水酸化ナトリウム、炭酸ナトリウムおよび
アンモニア水のうちの少なくとも一種の塩基を用いて行
われる特許請求の範囲第1項に記載のピロリジン誘導体
の製造方法。 7、式(II)化合物のヒドラジン分解が、無水ヒドラジ
ンおよびヒドラジン水化物のうちの少なくとも一種を、
式(II)化合物1モルに対して1〜5モルの量で使用し
て行われる特許請求の範囲第1項に記載のピロリシン誘
導体の製造方法。 8、前記ヒドラジン分解が、40℃と130℃との間の
温度で行われる特許請求の範囲第7項に記載のピロリジ
ン誘導体の製造方法。 9、エチレンジアミンが、式(II)化合物1モルに対し
1〜10モルの量で反応に供される特許請求の範囲第1
項に記載のピロリシン誘導体の製造方法。 10、10℃と80℃との間の温度で反応が行われる特
許請求の範囲第9項に記載のピロリジン誘導体の製造方
法。 11、四塩化炭素、クロロホルム、塩化メチレン、酢酸
エチル、テトラヒドロフラン、1,4−ジオキサンおよ
びアルコール類のうちの少なくとも一種の溶媒の存在下
または不存在下で反応が行われる特許請求の範囲第9項
に記載のピロリジン誘導体の製造方法。
[Claims] 1. A method for producing a compound of formula (I), comprising a step of reacting a compound of formula (III) with a compound of formula (IV) to obtain a compound of formula (II); by hydrolysis or hydrazinolysis, or by reacting with ethylenediamine,
Method for producing pyrrolidine derivatives, including the process of obtaining the compound of formula (I): ▲There are mathematical formulas, chemical formulas, tables, etc.▼・
...(I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼...(II) ▲There are mathematical formulas, chemical formulas, tables, etc.▼...(III) ▲There are mathematical formulas, chemical formulas, tables, etc.▼... (IV) where, For oxygen, n is 1), and M is a sodium or potassium atom. 2. The reaction between the compound of formula (III) and the compound of formula (IV) can be carried out in water, methanol, ethanol, isopropanol, acetone, 1,4-dioxane, tetrahydrofuran, N,N
- The method for producing a pyrrolidine derivative according to claim 1, which is carried out in at least one solvent of dimethylformamide and dimethyl sulfoxide or an aqueous solution thereof. 3. Claim 2, wherein the compound of formula (IV) is subjected to the reaction in an amount of 1 to 3 moles per 1 mole of the compound of formula (III)
A method for producing a pyrrolidine derivative according to section 1. 4. The method for producing a pyrrolysine derivative according to claim 2, wherein the reaction temperature is between 35°C and 120°C and the reaction time is between 30 minutes and 20 hours. 5. At least one base selected from sodium hydrogen carbonate, sodium carbonate, sodium hydroxide, potassium hydrogen carbonate, potassium carbonate, potassium hydroxide, sodium acetate, pyridine, and triethylamine is present in an amount of 0 per mole of the compound of formula (III). A process for producing pyrrolysine derivatives according to claim 2, wherein the pyrrolysine derivatives are used in an amount of .5 to 2.5 mol. 6. The compound according to claim 1, wherein the hydrolysis of the compound of formula (II) is carried out using at least one base selected from potassium hydroxide, potassium carbonate, sodium hydroxide, sodium carbonate, and aqueous ammonia. A method for producing a pyrrolidine derivative. 7. Hydrazine decomposition of the compound of formula (II) produces at least one of anhydrous hydrazine and hydrazine hydrate,
The method for producing a pyrrolysine derivative according to claim 1, which is carried out in an amount of 1 to 5 moles per mole of the compound of formula (II). 8. The method for producing a pyrrolidine derivative according to claim 7, wherein the hydrazine decomposition is carried out at a temperature between 40°C and 130°C. 9. Claim 1 in which ethylenediamine is subjected to the reaction in an amount of 1 to 10 moles per mole of the compound of formula (II)
A method for producing a pyrrolysine derivative according to section 1. 10. The method for producing pyrrolidine derivatives according to claim 9, wherein the reaction is carried out at a temperature between 10 and 80°C. Claim 9, wherein the reaction is carried out in the presence or absence of at least one solvent selected from the group consisting of 11. carbon tetrachloride, chloroform, methylene chloride, ethyl acetate, tetrahydrofuran, 1,4-dioxane, and alcohols. A method for producing a pyrrolidine derivative as described in .
JP60282703A 1985-02-11 1985-12-16 Manufacture of pyrrolidine derivative Pending JPS61183263A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019850000850A KR870001569B1 (en) 1985-02-11 1985-02-11 Preparing process for pyrolidine derivatives
KR85850 1985-02-11

Publications (1)

Publication Number Publication Date
JPS61183263A true JPS61183263A (en) 1986-08-15

Family

ID=19239706

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60282703A Pending JPS61183263A (en) 1985-02-11 1985-12-16 Manufacture of pyrrolidine derivative

Country Status (6)

Country Link
JP (1) JPS61183263A (en)
KR (1) KR870001569B1 (en)
DE (1) DE3538747A1 (en)
ES (1) ES8606269A1 (en)
FR (1) FR2577222B1 (en)
GB (1) GB2170806B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208954B (en) * 1990-09-21 1994-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing 1-(3-mercapto-(2s)-methyl-1-oxo-propyl)-l-prolyn
JPH04503662A (en) * 1988-08-26 1992-07-02 セプラコア,インコーポレーテッド Derivatives and precursors of captopril and its analogs
US5237073A (en) * 1988-08-26 1993-08-17 Sepracor, Inc. Derivatives and precursors of captopril and its analogues
KR940005014B1 (en) * 1991-11-07 1994-06-09 보령제약 주식회사 Process for producting pyrrolidine derivatives

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58189113A (en) * 1976-02-13 1983-11-04 イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド Hypotensive drug

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4192945A (en) * 1978-12-07 1980-03-11 E. R. Squibb & Sons, Inc. Process for preparing proline and homoproline derivatives
GB2065643B (en) * 1979-12-13 1983-08-24 Kanegafuchi Chemical Ind Optically active n-mercaptoalkanoylamino acids
HU184082B (en) * 1979-12-29 1984-06-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing 1-3-/3mercapto-/2s/-methyl-propinyl/-pyrrolidine-/2s/-carboxylic acid
JPS58124764A (en) * 1982-01-20 1983-07-25 Kanegafuchi Chem Ind Co Ltd Production of optically active thiol

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58189113A (en) * 1976-02-13 1983-11-04 イ−・ア−ル・スクイブ・アンド・サンズ・インコ−ポレイテツド Hypotensive drug

Also Published As

Publication number Publication date
DE3538747C2 (en) 1988-08-18
FR2577222B1 (en) 1987-12-24
GB8602782D0 (en) 1986-03-12
GB2170806A (en) 1986-08-13
KR870001569B1 (en) 1987-09-04
FR2577222A1 (en) 1986-08-14
KR860006441A (en) 1986-09-11
GB2170806B (en) 1988-08-03
ES548744A0 (en) 1986-04-01
ES8606269A1 (en) 1986-04-01
DE3538747A1 (en) 1986-08-14

Similar Documents

Publication Publication Date Title
DK118403C (en) Alpha-aminopenicillin derivatives and salts thereof for use as intermediates in the preparation of alpha-aminopenicillins.
KR20010053294A (en) Method for producing ortho-alkylated benzoic acid derivatives
JPS61183263A (en) Manufacture of pyrrolidine derivative
HUT54347A (en) Improved process for producing amidoximes
JPS60202859A (en) 3-aminoazetidin compound and manufacture
JPH04210957A (en) Process for preparing cyclopentene compound
JPH0737440B2 (en) Method for producing sulfonium compound
US3828070A (en) Aminoethanesulfonyl derivatives and their production
JP3046258B2 (en) Method for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof
JPH0217163A (en) Production of diaminomaleonitrile and diaminoacrylonitrile derivative
JPS6327475A (en) Manufacture of mercaptoacylproline
KR102704255B1 (en) Method for the preparation of Doxifluridine
JPS61218555A (en) Manufacture of acids substituted with trifluorodichloroethylgroup and zinc compounds
US4515958A (en) Process for preparing 1-alkyl-5-mercaptotetrazoles
KR100297802B1 (en) Method for preparing 2- (3-trifluoromethyl) anilinonicotinic acid 2- (N-morpholine) ethyl.
KR100288404B1 (en) 2-Benzothiazolyl 4-amino-5-chloro-2-methoxythiobenzoate And Process For Preparing Cisapride Employing The Same
JPS62195344A (en) Manufacture of novel intermediate
JPS625140B2 (en)
KR970006248B1 (en) Benzoyl-c-(5-methyl 1,3,4-thiadiazole-2-thio) imidoyl chloride derivatives and method for the production thereof
JPH01501002A (en) Synthesis of N-epoxypropyllactam
KR970001473B1 (en) Method for preparing pyrazole sulfonyl chloride derivatives
JPS645591B2 (en)
WO2019098551A1 (en) Method for preparing intermediate compound for synthesizing pharmaceutical
JPS5923314B2 (en) New pyrrole derivative
JPS59216882A (en) Production of 2,4-oxazolidinedione derivative